7 January 2025
CVS Group plc
("CVS" or the "Company")
PDMR Dealing
CVS, one of the UK's leading providers of integrated veterinary services, announces that it was made aware on 6 January 2025 that, as part of a dividend reinvestment plan, Joanne Shaw, Non-executive Director, purchased 14 ordinary shares of £0.002 each ("Ordinary Shares") at a price of 840.25 pence per Ordinary Share on 29 November 2024. Following this transaction, she holds a total of 1,562 Ordinary Shares, representing approximately 0.002% of the current Issued Share Capital of the Company.
The notification below, made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.
Contacts:
CVS Group plc via Camarco
Richard Fairman, CEO
Scott Morrison, Company Secretary
Peel Hunt LLP (Nominated Adviser & Broker) +44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark / Lalit Bose
Berenberg (Joint Broker) +44 (0)20 3207 7800
Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser
Camarco (Financial PR)
Geoffrey Pelham-Lane +44 (0)7733 124 226
Ginny Pulbrook +44 (0)7961 315 138
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
| 1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
| a) |
Name |
Joanne Shaw |
||||
| 2 |
Reason for the notification |
|||||
| a) |
Position/status |
PDMR (Non-Executive Director) |
||||
| b) |
Initial notification /Amendment |
Initial Notification |
||||
| 3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
| a) |
Name |
CVS Group plc |
||||
| b) |
LEI |
213800J41XDQ2NX48O05 |
||||
| 4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
| a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 0.2 pence each GB00B2863827 |
||||
| b) |
Nature of the transaction |
On-market purchase |
||||
| c) |
Price(s) and volume(s) |
|
||||
| d) |
Aggregated information - Aggregated volume - Price |
N/A - single transaction |
||||
| e) |
Date of the transaction |
29 November 2024 |
||||
| f) |
Place of the transaction |
London Stock Exchange - AIM (XLON) |
||||